Reply
A. Sidney Barritt, Eric S. Orman, Paul H. Hayashi – 25 May 2012
A. Sidney Barritt, Eric S. Orman, Paul H. Hayashi – 25 May 2012
Shirish Huprikar, Gopi Patel, Thomas Schiano, Jayant Kalpoe – 25 May 2012
Palaniappan Manickam – 25 May 2012
Benjamin L. Shneider – 25 May 2012
Parul D. Agarwal, Michael R. Lucey – 25 May 2012
Tomomitsu Matono, Masahiko Koda, Yoshikazu Murawaki – 23 May 2012 – A 68‐year‐old male with liver cirrhosis and hepatocellular carcinoma treated by radiofrequency ablation was hospitalized for right hepatic hydrothorax and ascites. Perflubutane injected into the peritoneal cavity after an ultrasonography contrast agent revealed jet‐like flow from the ascites to a pleural effusion, indicating a diaphragmatic defect. A hepatic hydrothorax was sutured under thoracoscopy and did not recur. An intraperitoneal injection of perflubutane enables a less‐invasive diagnosis of a diaphragmatic defect.
Tomomitsu Matono, Masahiko Koda, Yoshikazu Murawaki – 23 May 2012 – A 68‐year‐old male with liver cirrhosis and hepatocellular carcinoma treated by radiofrequency ablation was hospitalized for right hepatic hydrothorax and ascites. Perflubutane injected into the peritoneal cavity after an ultrasonography contrast agent revealed jet‐like flow from the ascites to a pleural effusion, indicating a diaphragmatic defect. A hepatic hydrothorax was sutured under thoracoscopy and did not recur. An intraperitoneal injection of perflubutane enables a less‐invasive diagnosis of a diaphragmatic defect.
Tetsuji Fujita – 22 May 2012
Abhisek Mitra, Jeffry Cutrera, Lopa Mishra, Shulin Li – 22 May 2012
Marcin Krawczyk, Monica Acalovschi, Frank Lammert – 22 May 2012